Sponsor or institution
Clinical trials and research at Centre Hospitalier Universitaire de la Guadeloupe
As of November 12, 2026, Find a Trial lists 17 clinical trials run by Centre Hospitalier Universitaire de la Guadeloupe that are recruiting, at sites in 4 countries (most in Guadeloupe (16), France (2), French Guiana (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 4Countries
Newest trials
All recruiting trials (17)
-
How PNPLA3 gene variants relate to fatty liver disease in the French Overseas Territories
This will test whether PNPLA3 gene changes help explain who develops more liver fat or liver inflammation among adults with MASLD in Guadeloupe, French Guiana, and Réunion.
-
Corin gene double variant (Thr555Ile and Glu568Pro) and high blood pressure risk in Afro‑Caribbean adults
This study will test whether two corin gene variants (Thr555Ile and Glu568Pro) are linked to high blood pressure in Afro‑Caribbean adults in Guadeloupe.
-
Factors linked to severe dermatomyositis in Caribbean adults
See if specific clinical, demographic, and ancestral factors are linked to more severe dermatomyositis in adults of Caribbean ancestry living in Guadeloupe.
-
Robotic remote echocardiography versus standard echocardiography for heart failure care in the Guadeloupe archipelago
This project will test whether robotic remote echocardiography gives the same left ventricular function measurements as standard in-person echocardiography for adults with or at risk for heart failure in the Guadeloupe islands.
-
Using next-generation sequencing to find infectious causes of acute encephalitis and myelitis in Guadeloupe
This project will try next-generation sequencing on samples from people in Guadeloupe with acute encephalitis or myelitis to find infectious causes that routine tests miss.
-
Multidisciplinary program to reduce blood chlordecone levels in Guadeloupe
This program tests whether free blood testing plus multidisciplinary support can help adults in Guadeloupe lower their chlordecone levels.
-
H. pylori in stomach cancers in the French West Indies
This project will test how common H. pylori infection is in adults newly diagnosed with stomach cancer in Guadeloupe.
-
Oral glucose tolerance testing to find hidden type 2 diabetes in at-risk people in Guadeloupe
This project will test whether an oral glucose tolerance test (OGTT) finds type 2 diabetes in adults of African or Indian origin in Guadeloupe who have normal fasting blood glucose but diabetes risk factors.
-
Chlordecone exposure and women's fertility
This project will test whether past exposure to the pesticide chlordecone is linked to lower anti-Mullerian hormone (AMH) levels in women aged 18–39 who seek infertility care in Guadeloupe.
-
Infrared thermal imaging of the diabetic foot in Guadeloupe
This will test whether infrared thermal imaging shows different foot temperatures in healthy adults, people with diabetes, and people with diabetic foot ulcers in Guadeloupe.
-
Regional anesthesia to reduce inflammation during vaso‑occlusive crises in sickle cell disease
This project will test whether giving regional (loco‑regional) anesthesia to adults hospitalized for sickle cell vaso‑occlusive crises reduces inflammatory markers and speeds recovery compared with usual care.
-
Why dengue is more severe in people with sickle cell disease
This project will test whether immune cells and tiny blood particles from young people with SC or SS sickle cell disease respond differently to dengue virus compared with healthy controls, which could explain more severe infections.
-
Ethnic differences in S100B blood levels among healthy adults in Guadeloupe
This project will test whether normal S100B protein blood levels differ by skin phenotype in healthy adults living and working in Guadeloupe.
-
Evaluating the role of autoantibodies in autoimmune hepatitis severity
This study is trying to see if certain autoantibodies in the blood can help us understand how severe autoimmune hepatitis is in patients.
-
Investigating the Role of Inflammasome in Platelet Activation During Sepsis
This study is trying to see how a specific part of the immune system affects platelets in people with different levels of sepsis caused by infections.
-
Impact of organochlorine pollutants on child development in Guadeloupe
This study looks at how exposure to a harmful insecticide affects the growth and development of children in Guadeloupe as they reach puberty.
-
Understanding factors affecting prostate cancer progression
This study is trying to find out what factors affect how prostate cancer grows in different people to help improve treatment and prevention for those at higher risk.
Quick answers
How many clinical trials run by Centre Hospitalier Universitaire de la Guadeloupe are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Guadeloupe (16 trials), France (2 trials), French Guiana (1 trial), Reunion (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.